Fangsheng Pharmaceutical: The company has always valued talent incentives, and establishing and improving long-term incentive mechanisms is an important measure to ensure the company's achievement of its strategic goals.

NightAirdropper · 2026-03-13T02:40:26+00:00

Fangsheng Pharmaceutical stated that it attaches importance to talent incentive mechanisms and has formulated a "Long-term Incentive System for Core Talents." The restricted stock incentive plan implemented in 2022 has been completed. In the future, the company will plan new incentive schemes based on its strategy and market conditions, while ensuring compliance with applicable laws and regulations in information disclosure.

NightAirdropper

2026-03-13 02:40:26

Abstract generation in progress

Securities Daily, March 10 — Fangsheng Pharmaceutical stated during a recent inquiry that the company has always valued talent incentives. Establishing and improving a long-term incentive mechanism is an important measure to ensure the company’s strategic goals. The company has developed the “Long-term Incentive System for Core Talents” to guide the design and implementation of its talent strategy. The restricted stock incentive plan implemented in 2022 has been completed, and new incentive plans are currently under ongoing planning and review. The specific plans will be formulated based on the company’s future strategy, development plans, and market conditions. If new incentive plans are introduced in the future, the company will strictly comply with relevant laws and regulations and fulfill its disclosure obligations in a timely manner.

(Editor: Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.